Publications:

Janus kinase 3: the controller and the controlled.

Acta Biochimica Et Biophysica Sinica

Wu, Wei W; Sun, Xiao-Hong XH

Publication Date: 2012-03

Variant appearance in text: JAK2: Y613E

PubMed Link: 22130498

Variant Present in the following documents:

• Main text

View BVdb publication page

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.

Journal Of Leukocyte Biology

Gery, Sigal S; Cao, Qi Q; Gueller, Saskia S; Xing, Hongtao H; Tefferi, Ayalew A; Koeffler, H Phillip HP

Publication Date: 2009-06

Variant appearance in text: JAK2: Y613E

PubMed Link: 19293402

Variant Present in the following documents:

• Main text

View BVdb publication page

The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice.

The Journal Of Biological Chemistry

Funakoshi-Tago, Megumi M; Tago, Kenji K; Sumi, Kazuya K; Abe, Miyuki M; Aizu-Yokota, Eriko E; Oshio, Tomoyuki T; Sonoda, Yoshiko Y; Kasahara, Tadashi T

Publication Date: 2009-05-08

Variant appearance in text: JAK2: Y613E

PubMed Link: 19289461

Variant Present in the following documents:

• Main text

View BVdb publication page

Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity.

Molecular And Cellular Biology

Funakoshi-Tago, Megumi M; Pelletier, Stéphane S; Moritake, Hiroshi H; Parganas, Evan E; Ihle, James N JN

Publication Date: 2008-03

Variant appearance in text: JAK2: Y613E

PubMed Link: 18160720

Variant Present in the following documents:

• Main text

View BVdb publication page